Diagnostic preparedness in Europe for detection of avian influenza A(H7N9) viruses
In China, a novel avian-origin reassortant influenza A(H7N9) virus has been detected in a number of human cases.
CNRL in silico exercise to determine the capabilities of network laboratories to detect triple reassortant swine origin influenza A(H3N2) viruses
Following the emergence of swine influenza A(H3N2) variant (v) viruses with sporadic human infections in North America, the Community Network of Reference Laboratories (CNRL) and the Animal Health and Veterinary Laboratories Agency completed an exercise to assess the CNRL’s capability to detect novel reassortant and circulating triple reassortant swine viruses (TRA) in humans.
Weekly influenza surveillance overview January 7, 2011 - Week 52
Generally, reporting of influenza has been less complete over weeks 51 and 52 due to the holiday period, which reduces consulting rates and reporting to national centres and subsequently onto ECDC. Nevertheless, in week 52/2010, 15 of the 25 countries reported increasing trends of influenza activity.
Toolkit for investigation of cases of Avian influenza in humans
In order to increase preparedness to respond to possible cases and clusters of Highly Pathogenic Avian Influenza A/H5N1 in humans in Europe, the ECDC has prepared a toolkit for the European Union member states.
Risk assessment: Avian Influenza A/H5N1 in Bathing and Potable (Drinking) Water and Risks to Human Health
Oseltamivir Prophylaxis Following Suspected Exposure of Humans to Highly Pathogenic Avian Influenza
Oseltamivir Prophylaxis Following Suspected Exposure of Humans to Highly Pathogenic Avian Influenza (HPAI) with Particular Reference to HPAI type A/H5N1.